Prevention of Disuse Muscle Atrophy by Dietary Ingestion of 8-Prenylnaringenin in Denervated Mice

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Mukai, Rie ^a   Horikawa, Hitomi ^a   Fujikura, Yutaka ^a   Kawamura, Tomoyuki ^a   Nemoto, Hisao ^a   Nikawa, Takeshi ^a   Terao, Junji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 PRENYLNARINGENIN; ATROGIN 1; NARINGENIN; PROTEIN KINASE B; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; DISUSE MUSCLE ATROPHY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GASTROCNEMIUS MUSCLE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE LEVEL; NONHUMAN; PRENYLATION; PROTEIN CONTENT; WEIGHT REDUCTION;

ANIMALS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; FLAVANONES; HUMULUS; MALE; MICE; MICE, INBRED C57BL; MUSCLE DENERVATION; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DISORDERS, ATROPHIC; PHOSPHORYLATION; POWDERS; PROTO-ONCOGENE PROTEINS C-AKT; WATER;

HUMULUS LUPULUS; MUS;

EID: 84866540322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045048     Document Type: Article

References (48)

1. Mukai R, Nakao R, Yamamoto H, Nikawa T, Takeda E, et al. (2010) Quercetin Prevents Unloading-Derived Disused Muscle Atrophy by Attenuating the Induction of Ubiquitin Ligases in Tail-Suspension Mice. J Nat Prod73: 1708-1710.
2. Terao J, (2009) Dietary flavonoids as antioxidants. Forum Nutr 61: 87-94.
3. Barron D, Ibrahim RK, (1996) Isoprenylated flavonoids - A survey. Phytochemistry 43: 921-982.
4. Botta B, Vitali A, Menendez P, Misiti D, Delle Monache G, (2005) Prenylated flavonoids: Pharmacology and biotechnology. Current Medicinal Chemistry 12: 713-739.
5. Huang X, Zhu D, Lou Y, (2007) A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells. Eur J Pharmacol 564: 26-36.
6. Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T, (1999) Antibacterial and antiandrogen flavonoids from Sophora flavescens. J Nat Prod 62: 1595-1599.
7. Lee MH, Kim JY, Ryu JH, (2005) Prenylflavones from Psoralea corylifolia inhibit nitric oxide synthase expression through the inhibition of I-kappaB-alpha degradation in activated microglial cells. Biol Pharm Bull 28: 2253-2257.
8. Lee HJ, Lyu da H, Koo U, Nam KW, Hong SS, et al. (2012) Protection of prenylated flavonoids from Mori Cortex Radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y cells. Archives of Pharmacal Research 35: 163-170.
9. Kretzschmar G, Zierau O, Wober J, Tischer S, Metz P, et al. (2010) Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein. Journal of Steroid Biochemistry and Molecular Biology 118: 1-6.
10. Arung ET, Shimizu K, Tanaka H, Kondo R, (2010) 3-Prenyl luteolin, a new prenylated flavone with melanin biosynthesis inhibitory activity from wood of Artocarpus heterophyllus. Fitoterapia 81: 640-643.
11. Sasaki K, Mito K, Ohara K, Yamamoto H, Yazaki K, (2008) Cloning and characterization of naringenin 8-prenyltransferase, a flavonoid-specific prenyltransferase of Sophora flavescens. Plant Physiol 146: 1075-1084.
12. Stevens JF, Taylor AW, Deinzer ML, (1999) Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography tandem mass spectrometry. Journal of Chromatography A 832: 97-107.
13. Stevens JF, Taylor AW, Clawson JE, Deinzer ML, (1999) Fate of xanthohumol and related prenylflavonoids from hops to beer. J Agric Food Chem 47: 2421-2428.
14. Guo J, Nikolic D, Chadwick LR, Pauli GF, van Breemen RB, (2006) Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.). Drug Metab Dispos 34: 1152-1159.
15. Bolca S, Possemiers S, Maervoet V, Huybrechts I, Heyerick A, et al. (2007) Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women. British Journal of Nutrition 98: 950-959.
16. Possemiers S, Bolca S, Grootaert C, Heyerick A, Decroos K, et al. (2006) The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr 136: 1862-1867.
17. Bowe J, Li XF, Kinsey-Jones J, Heyerick A, Brain S, et al. (2006) The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes. J Endocrinol 191: 399-405.
18. Humpel M, Isaksson P, Schaefer O, Kaufmann U, Ciana P, et al. (2005) Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J Steroid Biochem Mol Biol 97: 299-305.
19. Amer DA, Kretzschmar G, Muller N, Stanke N, Lindemann D, et al. (2010) Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line. J Steroid Biochem Mol Biol 120: 208-217.
20. Kawamura T, Hayashi M, Mukai R, Terao J, Nemoto H, (2012) An Efficient Method for C8-Prenylation of Flavonols and Flavanones. Synthesis 44: 1308-1314.
21. Tomas-Barberen FA, Clifford MN, (2000) Flavanones, chalcones and dihydrochalcones- nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture 80: 1073-1080.
22. McClung JM, Davis JM, Wilson MA, Goldsmith EC, Carson JA, (2006) Estrogen status and skeletal muscle recovery from disuse atrophy. J Appl Physiol 100: 2012-2023.
23. Brown M, Foley A, Ferreria JA, (2005) Ovariectomy, hindlimb unweighting, and recovery effects on skeletal muscle in adult rats. Aviat Space Environ Med 76: 1012-1018.
24. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL, (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proceedings of the National Academy of Sciences of the United States of America 98: 14440-14445.
25. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708.
26. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, et al. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
27. Senf SM, Dodd SL, McClung JM, Judge AR, (2008) Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB Journal 22: 3836-3845.
28. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, et al. (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Molecular Cell 14: 395-403.
29. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, et al. (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019.
30. McClung JM, Davis JM, Wilson MA, Goldsmith EC, Carson JA, (2006) Estrogen status and skeletal muscle recovery from disuse atrophy. Journal of Applied Physiology 100: 2012-2023.
31. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248-254.
32. Zhang P, Chen X, Fan M, (2007) Signaling mechanisms involved in disuse muscle atrophy. Med Hypotheses 69: 310-321.
33. English KL, Paddon-Jones D, (2010) Protecting muscle mass and function in older adults during bed rest. Curr Opin Clin Nutr Metab Care 13: 34-39.
34. Fang T, Wang Y, Ma Y, Su W, Bai Y, et al. (2006) A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma. J Pharm Biomed Anal 40: 454-459.
35. Hsiu SL, Huang TY, Hou YC, Chin DH, Chao PD, (2002) Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci 70: 1481-1489.
36. Rad M, Humpel M, Schaefer O, Schoemaker RC, Schleuning WD, et al. (2006) Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br J Clin Pharmacol 62: 288-296.
37. Williamson G, Barron D, Shimoi K, Terao J, (2005) In vitro biological properties of flavonoid conjugates found in vivo. Free Radical Research 39: 457-469.
38. Bieger J, Cermak R, Blank R, de Boer VC, Hollman PC, et al. (2008) Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138: 1417-1420.
39. Shimoi K, Nakayama T, (2005) Glucuronidase deconjugation in inflammation. Methods Enzymol 400: 263-272.
40. Terao J, Murota K, Kawai Y, (2011) Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo. Food Funct 2: 11-17.
41. Menendez C, Duenas M, Galindo P, Gonzalez-Manzano S, Jimenez R, et al. (2011) Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? Mol Nutr Food Res 55: 1780-1790.
42. Barron D, Balland C, Possety F, Ravanel P, Desfougeres A, (1996) Prenyl flavonoids and membrane permeability. Acta Botanica Gallica 143: 509-520.
43. Pang Y, Nikolic D, Zhu D, Chadwick LR, Pauli GF, et al. (2007) Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells. Mol Nutr Food Res 51: 872-879.
44. Milligan SR, Kalita JC, Pocock V, Van de Kauter V, Stevens JF, et al. (2000) The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. Journal of Clinical Endocrinology & Metabolism 85: 4912-4915.
45. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, et al. (1999) Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. Journal of Clinical Endocrinology & Metabolism 84: 2249-2252.
46. Coldham NG, Sauer MJ, (2001) Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food and Chemical Toxicology 39: 1211-1224.
47. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, et al. (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3: 1009-1013.
48. Bolca S, Li J, Nikolic D, Roche N, Blondeel P, et al. (2010) Disposition of hop prenylflavonoids in human breast tissue. Mol Nutr Food Res 54Suppl 2: S284-294.